Two new abstracts released at the American Academy of Ophthalmology (AAO) showed mixed results about the impact of anti-glucagon-like peptide 1 (GLP-1) drugs’ impact on the eye. One found GLP-1 drugs can increase the risk of diabetic…

Two new abstracts released at the American Academy of Ophthalmology (AAO) showed mixed results about the impact of anti-glucagon-like peptide 1 (GLP-1) drugs’ impact on the eye. One found GLP-1 drugs can increase the risk of diabetic…